French Supreme Court in Finasteride second-medical use litigation acknowledges patentability of dosage regime claims By Annsley Merelle Ward on Thursday, January 11, 2018 actavis AmeriKat dosage dosage regime patents french patent law French supreme court MSD Second medical use Teva +
BREAKING: CJEU holds that SPCs cannot be obtained on the basis of an "end of procedure notice" pursuant to Article 3(b) SPC Regulation By Annsley Merelle Ward on Thursday, December 07, 2017 AmeriKat Article 3(b) CJEU comptroller Merck MSD SPC SPC regulation SPCs +